In silico analysis for determining the deleterious nonsynonymous single nucleotide polymorphisms of BRCA genes
- PMID: 32042831
- PMCID: PMC6995337
- DOI: 10.22099/mbrc.2019.34198.1420
In silico analysis for determining the deleterious nonsynonymous single nucleotide polymorphisms of BRCA genes
Abstract
Recent advances in DNA sequencing techniques have led to an increase in the identification of single nucleotide polymorphisms (SNPs) in BRCA1 and BRCA2 genes, but no further information regarding the deleterious probability of many of them is available (Variants of Unknown Significance/VUS). As a result, in the current study, different sequence- and structure-based computational tools including SIFT, PolyPhen2, PANTHER, SNPs&GO, FATHMM, SNAP, PhD-SNP, Align-GVGD, and I-Mutant were utilized for determining how resulted BRCA protein is affected by corresponding missense mutations. FoldX was used to estimate mutational effects on the structural stability of BRCA proteins. Variants were considered extremely deleterious only when all tools predicted them to be deleterious. A total of 10 VUSs in BRCA1 (Cys39Ser, Cys64Gly, Phe861Cys, Arg1699Pro, Trp1718Cys, Phe1761Ser, Gly1788Asp, Val1804Gly, Trp1837Gly, and Trp1837Cys) and 12 in BRCA2 (Leu2510Pro, Asp2611Gly, Tyr2660Asp, Leu2686Pro, Leu2688Pro, Tyr2726Cys, Leu2792Pro, Gly2812Glu, Gly2813Glu, Arg2842Cys, Asp3073Gly, and Gly3076Val) were considered as extremely deleterious. Results suggested that deleterious variants were mostly enriched in the N- and C-terminal domain of the BRCA1 and BRCA2 C-terminus. Utilizing evolutionary conservation analysis, we demonstrated that the majority of deleterious SNPs ensue in highly conserved regions of BRCA genes. Furthermore, utilizing FoldX, we demonstrated that alterations in the function of proteins are not always together with stability alterations.
Keywords: BRCA genes; SNPs; computational tools; evolutionary analysis.
Conflict of interest statement
Authors have no competing interests
Figures




Similar articles
-
Evolution- and structure-based computational strategy reveals the impact of deleterious missense mutations on MODY 2 (maturity-onset diabetes of the young, type 2).Theranostics. 2014 Jan 29;4(4):366-85. doi: 10.7150/thno.7473. eCollection 2014. Theranostics. 2014. PMID: 24578721 Free PMC article.
-
Determination of deleterious single-nucleotide polymorphisms of human LYZ C gene: an in silico study.J Genet Eng Biotechnol. 2022 Jul 1;20(1):92. doi: 10.1186/s43141-022-00383-8. J Genet Eng Biotechnol. 2022. PMID: 35776277 Free PMC article.
-
Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics.BMC Med Genomics. 2018 Mar 27;11(1):35. doi: 10.1186/s12920-018-0353-y. BMC Med Genomics. 2018. PMID: 29580235 Free PMC article.
-
Pitfalls and caveats in BRCA sequencing.Ultrastruct Pathol. 2006 May-Jun;30(3):229-35. doi: 10.1080/01913120500521281. Ultrastruct Pathol. 2006. PMID: 16825125 Review.
-
Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants.Klin Onkol. 2019 Summer;32(Supplementum2):51-71. doi: 10.14735/amko2019S51. Klin Onkol. 2019. PMID: 31409081 Review. English.
Cited by
-
Evolutionary expansion and expression dynamics of cytokinin-catabolizing CKX gene family in the modern amphidiploid mustard (Brassica sp.).3 Biotech. 2022 Sep;12(9):233. doi: 10.1007/s13205-022-03294-0. Epub 2022 Aug 19. 3 Biotech. 2022. PMID: 35996674 Free PMC article.
-
In-Silico Analyses of Nonsynonymous Variants in the BRCA1 Gene.Biochem Genet. 2021 Dec;59(6):1506-1526. doi: 10.1007/s10528-021-10074-7. Epub 2021 May 4. Biochem Genet. 2021. PMID: 33945048
-
Analysis and comparison of physiochemical properties, mutations and glycosylation patterns between RNA polymerase and membrane protein of SARS-CoV and SARS-CoV-2.Mol Biol Res Commun. 2021 Dec;10(4):171-178. doi: 10.22099/mbrc.2021.42187.1692. Mol Biol Res Commun. 2021. PMID: 35097139 Free PMC article.
-
K3326X and Other C-Terminal BRCA2 Variants Implicated in Hereditary Cancer Syndromes: A Review.Cancers (Basel). 2021 Jan 25;13(3):447. doi: 10.3390/cancers13030447. Cancers (Basel). 2021. PMID: 33503928 Free PMC article. Review.
-
Genome interpretation using in silico predictors of variant impact.Hum Genet. 2022 Oct;141(10):1549-1577. doi: 10.1007/s00439-022-02457-6. Epub 2022 Apr 30. Hum Genet. 2022. PMID: 35488922 Free PMC article. Review.
References
-
- Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF, Venter DJ. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Cancer Epidem Biomar. 1999;8:741–747. - PubMed
-
- Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MC, Hwang LY, Bowcock AM, Baer R. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet. 1996;14:430–440. - PubMed
-
- Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell. 1997;88:265–275. - PubMed
-
- Koonin EV, Altschul SF, Bork P. BRCA1 protein products. .. Functional motifs... Nat Genet. 1996;13:266–268. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous